NCT01121185View on ClinicalTrials.gov

Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C

PHASE2TerminatedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
HCV InfectionLiver Transplantation
Interventions
BIOLOGICAL

MBL-HCV1

50 mg/kg MBL-HCV1, intravenous

OTHER

0.9% Sodium chloride Placebo

0.9% sodium chloride, intravenous

Trial Locations (8)

10029

Mount Sinai Hospital, New York

38104

Methodist Healthcare Foundation, Memphis

44195

Cleveland Clinic Foundation, Cleveland

48202

Henry Ford Health System, Detroit

06504

Yale-New Haven Hospital, New Haven

02114

Massachusetts General Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

01805

Lahey Clinic, Burlington

Sponsors

Lead Sponsor

MassBiologics
All Listed Sponsors
lead

MassBiologics

OTHER

NCT01121185 - Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C | Biotech Hunter | Biotech Hunter